NeoGenomics, Inc. (NEO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-TESTING LABORATORIES

12701 COMMONWEALTH DRIVE FORT MYERS, FL 33913

NeoGenomics operates a network of cancer-focused testing laboratories that provides genetic and molecular testing services, including: Cytogenetics testing, which studies normal and abnormal chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization testing, which detects and locates the presence or absence of certain deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which measures the characteristics of cell populations; immunohistochemistry testing, which identifies cell proteins in a tissue section; and molecular testing, which analyzes the DNA and ribonucleic, and the structure and function of genes at a molecular level.

Data based on most recent fiscal year report
Market Cap651.321 Million Shares Outstanding80.41 Million Avg Volume553.223 Thousand
1-Yr BETA vs S&P TR0 Current Ratio2.42 Quick Ratio2.21
View SEC Filings from NEO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade NEO now:
Filers who had this stock in their top 10: 9 2 (0.21%)
13F Filers holding this stock: 248 25 (2.58%)
Aggregate 13F shares on 06/30/2019: 88.1 Million 5.405 Million
Aggregate 13F shares on 03/31/2019: 80.43 Million 5.48 Million
Percent change: 9.54% -1.37%
Funds creating new positions: 40 8
Funds Adding to an existing position: 109 10
Funds closing out their position: 22 3
Funds reducing their position: 67 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 

NeoGenomics, Inc. Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Funds Holding NEO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

311 Thousand total shares from 13 transactions

Exercise Derivative Conversion (M)

37.8 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CROWTHER BRUCE K

  • Director
 34,503 2019-09-30 1

MURPHY KIERAN PIUS SENIOR VICE PRESIDENT

  • Officer
 94,205 2019-09-11 0

HANNAH ALISON L.

  • Director
 76,098 2019-09-09 2

JONES STEVEN C

  • Director
 488,767 2019-09-06 6

VAN OORT DOUGLAS M CHAIRMAN AND CEO

  • Officer
  • Director
 2,214,089 2019-08-28 3

BONELLO WILLIAM CHIEF STRATEGY OFFICER

  • Officer
 6,735 2019-08-28 4

HIPP RAYMOND R

  • Director
 134,102 2019-08-23 4

JOHNSON KEVIN C

  • Director
 28,285 2019-08-23 5

TETRAULT LYNN A.

  • Director
 41,653 2019-06-06 3

KANOVSKY STEPHEN M

  • Director
 3,419 2019-06-06 1

SHOVLIN ROBERT J. PRESIDENT, CLINICAL SERVICES

  • Officer
 155,748 2019-05-25 5

CARDOZA GEORGE PRESIDENT, PHARMA SERVICES

  • Officer
 320,831 2019-05-02 3

BALLIET JENNIFER VP AND CHIEF CULTURE OFFICER

  • Officer
 22,862 2019-05-02 4

MCKENZIE KATHRYN B PRINCIPAL ACCOUNTING OFFICER

  • Officer
 2,273 2019-03-01 1

VIRAG SHARON CHIEF FINANCIAL OFFICER

  • Officer
 10,944 2019-03-01 1

WEISS LAWRENCE MARTIN CHIEF SCIENTIFIC OFFICER

  • Officer
 5,893 2019-03-01 3

GENERAL ELECTRIC CO

GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.

  • FORMER 10% OWNERFORMER 10% OWNER
 No longer subject to file 2018-12-14 2

BRODIE STEVEN G. VP - PHARMA OPERATIONS

  • Officer
 45,953 2018-10-22 1

ROSS STEVEN A CIO

  • Officer
 9,000 2018-05-10 0

BYWATER STEPHANIE K CHIEF COMPLIANCE OFFICER

  • Officer
 528 2018-05-01 0

DENT MICHAEL T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
 0 2018-02-15 0

ROBISON WILLIAM J

  • Director
 359,474 2017-05-25 0

ALBITAR MAHER CHIEF MEDICAL OFFICER

  • Officer
 60,692 2017-04-28 0

MACHULCZ MARK ALAN VICE PRESIDENT OF OPERATIONS

  • Officer
 0 2016-01-28 0

HOREL ROBERT H. VICE PRESIDENT GM PATHLOGIC

  • Officer
 51,218 2015-12-29 0

JONES STEVEN C EXECUTIVE VP OF FINANCE

ASPEN SELECT HEALTHCARE LP

  • Officer
  • 10% Owner
 3,886,629 2015-11-25 0

SMITS MARK W SVP-COMMERCIAL OPERATIONS

  • Officer
 9,608 2015-06-01 0

GASPARINI ROBERT P CHIEF SCIENCE OFFICER

  • Officer
 8,439 2014-05-22 0

KINDERHOOK, LP

KINDERHOOK GP LLC

KINDERHOOK PARTNERS, LLC

SHAH TUSHAR

CLEARMAN STEPHEN J

  • 10% Owner
 5,459,517 2014-01-09 0

DVONCH JEROME J PRINICPAL ACCOUNTING OFFICER

  • Officer
 0 2011-05-02 0

MILLER MARYDAWN VICE PRESIDENT OF IT

  • Officer
 0 2011-05-02 0

PETERSON PETER M

  • Director
  • 10% Owner
 8,191,550 2011-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

JONES STEVEN C - Director shares owned in ira, custodian accounts, and trusts for the family of steven jones

2019-09-10 G 3,400 d 43,057 488,767.00 indirect

JONES STEVEN C - Director shares owned in ira, custodian accounts, and trusts for the family of steven jones

2019-09-10 S 1,200 $21.47 d 46,457 488,767.00 indirect

HANNAH ALISON L. - Director

2019-09-09 M 8,333 $9.11 d 0 76,098.00 direct

HANNAH ALISON L. - Director

2019-09-09 M 3,333 $6.66 a 67,765 76,098.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-09-09 S 3 $25.00 d 1,676,230 488,767.00 indirect

HANNAH ALISON L. - Director

2019-09-09 M 3,333 $6.66 d 0 76,098.00 direct

HANNAH ALISON L. - Director

2019-09-09 M 8,333 $9.11 a 76,098 76,098.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-09-06 S 1,691 $25.00 d 1,676,233 488,767.00 indirect

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-30 S 1,200 $25.00 d 1,677,924 2,171,291.00 indirect

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO

2019-08-29 G 10,000 d 2,016,589 2,214,089.00 direct

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO custodial account for child

2019-08-28 G 10,000 a 10,000 2,214,089.00 indirect

BONELLO WILLIAM - Officer CHIEF STRATEGY OFFICER

2019-08-28 S 17,000 $24.83 d 6,735 6,735.00 direct

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO

2019-08-28 G 10,000 d 2,026,589 2,214,089.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-28 S 39,537 $25.02 d 1,679,124 2,171,291.00 indirect

BONELLO WILLIAM - Officer CHIEF STRATEGY OFFICER

2019-08-28 M 17,000 $7.52 a 23,735 6,735.00 direct

VAN OORT DOUGLAS M - Director - Officer CHAIRMAN AND CEO

2019-08-28 G 30,000 d 2,036,589 2,214,089.00 direct

BONELLO WILLIAM - Officer CHIEF STRATEGY OFFICER

2019-08-28 M 17,000 d 55,763 6,735.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-27 S 30,280 $24.95 d 1,718,661 2,212,028.00 indirect

HIPP RAYMOND R - Director

2019-08-26 S 15,424 $24.79 d 134,102 134,102.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-26 S 143,603 $24.87 d 1,748,941 2,212,028.00 indirect

JOHNSON KEVIN C - Director

2019-08-26 S 11,800 $24.74 d 28,285 28,285.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-08-23 S 7,456 $25.72 d 1,892,544 2,212,028.00 indirect

JOHNSON KEVIN C - Director

2019-08-23 S 41,200 $25.60 d 40,085 28,285.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 2,777 d 0 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 2,777 $9.11 a 150,126 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,017 d 0 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,333 $7.27 a 147,349 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,333 d 3,334 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 S 600 $25.02 d 149,526 134,102.00 direct

HIPP RAYMOND R - Director

2019-08-23 M 3,017 $11.60 a 144,016 134,102.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments